Lagerstandorte

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Vorbehaltlich Verfügbarkeit

Dokumentation

MSDS herunterladen

Beispiel-COA herunterladen

Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.

1350716-67-4Moxifloxacin EP Impurity F

● Auf Lager

Katalog-Nr.::	VL106009
CAS-Nr.::	1350716-67-4
Summenformel::	C22H27ClFN3O4
Molare Masse::	451.92 g/mol

Angebot anfordern

Zur RFQ-Liste hinzufügen

Zusätzliche Informationen zu CAS 1350716-67-4

Parent drug

Moxifloxacin

IUPAC-Name

1-Cyclopropyl-6-fluoro-8-methoxy-7-(1-methyloctahydro-6H-pyrrolo[3, 4-b]pyridin-6-yl)-4-oxo-1, 4- dihydroquinoline-3-carboxylic acid hydrochloride

Pharmakopöe-Synonyme

Moxifloxacin Related Compound F

Other Synonyms

N-Methyl Moxifloxacin HCl; 7-[(4aS,7aS)-1-methyl-3,4,4a,5,7,7a-hexahydro-2H-pyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid;hydrochloride

SMILES

CN1CCC[C@@H]2[C@H]1CN(C2)C3=C(C=C4C(=C3OC)N(C=C(C4=O)C(=O)O)C5CC5)F.Cl

InChI

InChI=1S/C22H26FN3O4.ClH/c1-24-7-3-4-12-9-25(11-17(12)24)19-16(23)8-14-18(21(19)30-2)26(13-5-6-13)10-15(20(14)27)22(28)29;/h8,10,12-13,17H,3-7,9,11H2,1-2H3,(H,28,29);1H/t12-,17+;/m0./s1

Beschreibung

Moxifloxacin Related Compound F (CAS No. 1350716-67-4) is an impurity present in Moxifloxacin, Moxifloxacin is a quinolone or fluoroquinolone antibiotic, Moxifloxacin can be used to treat infections caused by the following bacteria, Aerobic Gram-positive microorganisms, Corynebacterium species, Micrococcus luteus, Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus haemolyticus, also is used for the treatment of respiratory tract, pelvic inflammatory disease, skin, and intra-abdominal infections.

References

„Tulkens, P. M., Arvis, P., & Kruesmann, F. (2012). Moxifloxacin Safety. Drugs in R&D, 12(2), 71â€“100. https://doi.org/10.2165/11634300-000000000-00000 â€Œ“